REGENXBIO is a biotechnology company that develops gene therapies for patients with rare genetic diseases. The company's pipeline includes treatments for spinal muscular atrophy, wet age-related macular degeneration, and phenylketonuria. REGENXBIO was founded in 2008 and is headquartered in Rockville, MD.